Mei Baisong 4
4 · Editas Medicine, Inc. · Filed Jul 20, 2022
Insider Transaction Report
Form 4
Mei Baisong
SVP, CHIEF MEDICAL OFFICER
Transactions
- Award
Common Stock
2022-07-18+58,372→ 58,372 total - Award
Stock Option (right to buy)
2022-07-18+171,602→ 171,602 totalExercise: $14.99Exp: 2032-07-17→ Common Stock (171,602 underlying)
Footnotes (2)
- [F1]The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on July 18, 2023 continuing through July 18, 2026.
- [F2]This option was granted on July 18, 2022 and is scheduled to vest over four years, with 25% of the shares to vest on July 18, 2023 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 18, 2026.